The dataset included survey responses from 286 vaccinated (Corbevax) respondents' samples detailing their demographics, daily activities, type of gastronomic preferences, and any prior illnesses. The data were collected between March 24, 2022, and April 26, 2022. After analysis, 70.98% of respondents who took the first dose of the medication experienced side effects, while 50.62% of respondents who took the second dose of the medication stated the same. The major side effects reported were injection site pain, fever, tiredness, body ache, headache, etc. Conclusion: After conducting a poll on children (aged 12-18) who had received the COVID-19 vaccination, we concluded that immunizations rarely cause moderate side effects that are manageable.
Keyphrases
- coronavirus disease
- sars cov
- chronic pain
- healthcare
- adverse drug
- young adults
- pain management
- respiratory syndrome coronavirus
- electronic health record
- cross sectional
- neuropathic pain
- high intensity
- quality improvement
- emergency department
- depressive symptoms
- ultrasound guided
- decision making
- drug induced
- postoperative pain